{
  "meta": {
    "title": "Weakness_Neuromuscular_Dysfunction",
    "url": "https://brainandscalpel.vercel.app/weakness-neuromuscular-dysfunction-862bb8df.html",
    "scrapedAt": "2025-11-29T18:25:11.150Z"
  },
  "questions": [
    {
      "id": 20007,
      "choices": [
        {
          "id": 79989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Upper motor neuron (UMN) lesions </span></span></p>"
        },
        {
          "id": 79990,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lower motor neuron (LMN) lesions </span></span></p>"
        },
        {
          "id": 79991,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Neuromuscular junction (NMJ) lesions </span></span></p>"
        },
        {
          "id": 79992,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man presents with progressive weakness in his right arm and leg, difficulty climbing stairs, and smaller, less legible handwriting. Exam reveals increased tone and brisk reflexes in the right extremities, along with a positive Babinski sign. Which of the following is the most likely impairment?</span></span></p>",
      "unique_key": "Q1777451",
      "question_audio": null,
      "question_video": null,
      "map_id": 19980,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Upper motor neuron (UMN) lesions</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Progressive weakness, increased tone (spasticity), brisk reflexes, and a positive Babinski sign are all hallmark signs of UMN lesions.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lower motor neuron (LMN) lesions:</strong>&nbsp;LMN lesions present with weakness, decreased reflexes, atrophy, and fasciculations. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Neuromuscular junction (NMJ) lesions:</strong> NMJ lesions (e.g., myasthenia gravis) cause fatigable weakness and typically have normal reflexes. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Myopathy:</strong> Myopathies cause weakness with normal reflexes and tone, affecting proximal muscles.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the clinical features that distinguish UMN lesions from other neuromuscular disorders.</span></span></p>",
      "correct_choice_id": 79989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20008,
      "choices": [
        {
          "id": 79993,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Electromyography (EMG) and nerve conduction studies (NCS) </span></span></p>"
        },
        {
          "id": 79994,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lumbar puncture </span></span></p>"
        },
        {
          "id": 79995,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Magnetic resonance imaging (MRI) of the brain </span></span></p>"
        },
        {
          "id": 79996,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Muscle biopsy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with hypertension presents with progressive weakness and atrophy of the intrinsic muscles of his left hand, diminished reflexes, and no Babinski sign. What is the most appropriate next step in evaluation?</span></span></p>",
      "unique_key": "Q3776428",
      "question_audio": null,
      "question_video": null,
      "map_id": 19981,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong><strong> A) Electromyography (EMG) and nerve conduction studies (NCS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">EMG/NCS are the most appropriate next step to assess for a lower motor neuron (LMN) or peripheral nerve lesion, which is suggested by the weakness, atrophy, and diminished reflexes.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lumbar puncture:</strong> Lumbar puncture is not indicated for suspected peripheral nerve lesions. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Magnetic resonance imaging (MRI) of the brain:</strong> Brain MRI would be useful for central nervous system (CNS) lesions, but not for peripheral issues. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Muscle biopsy:</strong> Muscle biopsy may be needed later, but EMG/NCS is the initial step to localize the lesion.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the utility of EMG/NCS in evaluating suspected LMN or peripheral nerve disorders.</span></span></p>",
      "correct_choice_id": 79993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20016,
      "choices": [
        {
          "id": 80025,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">UMN lesions </span></span></p>"
        },
        {
          "id": 80026,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LMN lesions </span></span></p>"
        },
        {
          "id": 80027,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">NMJ lesions </span></span></p>"
        },
        {
          "id": 80028,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents with fluctuating weakness and fatigue, worsening with activity, ptosis, diplopia, and proximal muscle weakness. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q4270849",
      "question_audio": null,
      "question_video": null,
      "map_id": 19989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong> <strong>C) NMJ lesions</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The fluctuating weakness, ocular symptoms (ptosis, diplopia), and fatigability strongly suggest a neuromuscular junction (NMJ) disorder like myasthenia gravis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. UMN lesions:</strong> Would not present with fluctuating weakness and fatigability. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. LMN lesions:</strong> Do not typically involve ocular muscles and have more consistent weakness. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Myopathy:</strong> Myopathies present with symmetrical proximal weakness without the fluctuating nature.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the characteristic features of NMJ disorders, such as myasthenia gravis, including fluctuating weakness and ocular involvement.</span></span></p>",
      "correct_choice_id": 80027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20017,
      "choices": [
        {
          "id": 80029,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">UMN lesions </span></span></p>"
        },
        {
          "id": 80030,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LMN lesions </span></span></p>"
        },
        {
          "id": 80031,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">NMJ lesions </span></span></p>"
        },
        {
          "id": 80032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with a 4-month history of progressive proximal muscle weakness, with difficulty climbing stairs, rising from a chair, and lifting objects overhead. Exam reveals symmetrical proximal muscle weakness with preserved distal strength. Muscle tone and reflexes are normal. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6039999",
      "question_audio": null,
      "question_video": null,
      "map_id": 19990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>D) Myopathy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Symmetrical proximal muscle weakness without sensory or reflex abnormalities is the classic presentation of a myopathy, a disorder primarily affecting muscle tissue.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. UMN lesions</strong>: UMN lesions would cause spasticity and hyperreflexia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. LMN lesions</strong>: LMN lesions would cause weakness, atrophy, and fasciculations. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. NMJ lesions</strong>:&nbsp;NMJ lesions<strong>&nbsp;</strong>Would cause fluctuating weakness and fatigability.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the characteristic presentation of myopathy, a disorder primarily affecting muscle tissue.</span></span></p>",
      "correct_choice_id": 80032,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20021,
      "choices": [
        {
          "id": 80045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cauda equina syndrome </span></span></p>"
        },
        {
          "id": 80046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Central cord syndrome </span></span></p>"
        },
        {
          "id": 80047,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior cord syndrome </span></span></p>"
        },
        {
          "id": 80048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete spinal cord transection</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 32-year-old man presents with complete loss of sensation and movement in both legs below the umbilicus after a motorcycle accident. He also reports loss of bladder and bowel control. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2447820",
      "question_audio": null,
      "question_video": null,
      "map_id": 19994,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong> <strong>D) Complete spinal cord transection</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete loss of sensation and motor function below a specific level, along with loss of bowel and bladder control, is indicative of a complete spinal cord transection.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Cauda equina syndrome:</strong> Causes lower back pain, radicular pain, saddle anesthesia, and bowel/bladder dysfunction, but usually not complete paralysis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Central cord syndrome:</strong> Typically presents with greater weakness in the upper extremities. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Anterior cord syndrome:</strong> Causes loss of motor function and pain/temperature sensation below the lesion, but proprioception is preserved.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the signs of complete spinal cord transection, a devastating injury with complete loss of sensory and motor function below the level of injury.</span></span></p>",
      "correct_choice_id": 80048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20023,
      "choices": [
        {
          "id": 80053,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C5-C6 </span></span></p>"
        },
        {
          "id": 80054,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">T5-T6 </span></span></p>"
        },
        {
          "id": 80055,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">L1-L2 </span></span></p>"
        },
        {
          "id": 80056,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">S1-S2</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old woman was stabbed in the back and now has decreased sensation on the right side of her body and weakness in her left leg. She has decreased pain and temperature sensation on the right below the mid-thorax, and decreased strength and vibratory/proprioceptive sensation on the left below the mid-thorax. What is the most likely spinal level of the injury?</span></span></p>",
      "unique_key": "Q8418357",
      "question_audio": null,
      "question_video": null,
      "map_id": 19996,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B) T5-T6</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This presentation is characteristic of Brown-S&eacute;quard syndrome, a hemisection of the spinal cord. The sensory level corresponds to the mid-thorax, indicating injury around T5-T6.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>C5-C6</strong>: C5-C6 would involve the arms and upper chest. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. L1-L2</strong>: L1-L2 would affect the legs and lower abdomen. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. S1-S2</strong>: S1-S2 would affect the perineal area and bowel/bladder function.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the patterns of sensory and motor loss in Brown-S&eacute;quard syndrome and how to localize the spinal level of injury.</span></span></p>",
      "correct_choice_id": 80054,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20026,
      "choices": [
        {
          "id": 80065,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Brown-S&eacute;quard syndrome </span></span></p>"
        },
        {
          "id": 80066,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Central cord syndrome </span></span></p>"
        },
        {
          "id": 80067,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior cord syndrome </span></span></p>"
        },
        {
          "id": 80068,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Conus medullaris syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with cervical spondylosis presents with weakness in both arms after a fall, more severe than in his legs. He also has difficulty with fine motor tasks. Exam shows greater upper extremity weakness with preserved sensation. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q3524490",
      "question_audio": null,
      "question_video": null,
      "map_id": 19999,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B) Central cord syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Central cord syndrome classically presents with greater weakness in the upper extremities compared to the lower extremities, often due to hyperextension injuries in patients with pre-existing cervical spondylosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Brown-S&eacute;quard syndrome:</strong>&nbsp;Brown-S&eacute;quard syndrome involves ipsilateral motor weakness and contralateral pain/temperature loss. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Anterior cord syndrome:</strong> Anterior cord syndrome causes loss of motor function and pain/temperature sensation below the lesion, with preserved proprioception. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Conus medullaris syndrome:</strong> Conus medullaris syndrome affects the sacral cord and causes bowel/bladder dysfunction and saddle anesthesia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the typical presentation of central cord syndrome, which is greater weakness in the upper extremities compared to the lower extremities.</span></span></p>",
      "correct_choice_id": 80066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20027,
      "choices": [
        {
          "id": 80069,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Disc protrusion </span></span></p>"
        },
        {
          "id": 80070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior spinal artery thrombosis </span></span></p>"
        },
        {
          "id": 80071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hyperflexion injury </span></span></p>"
        },
        {
          "id": 80072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Syringomyelia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with severe atherosclerosis has sudden paralysis and loss of pain and temperature sensation in both legs, along with urinary retention. Vibration and proprioception are intact. What is the LEAST likely cause?</span></span></p>",
      "unique_key": "Q2698144",
      "question_audio": null,
      "question_video": null,
      "map_id": 20000,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>D) Syringomyelia</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The sudden onset of paralysis, loss of pain/temperature sensation with preserved proprioception, and urinary retention points to anterior cord syndrome, typically caused by vascular issues like thrombosis in a patient with atherosclerosis. Syringomyelia is a slow-developing central cord lesion.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Disc protrusion, Option B. Anterior spinal artery thrombosis </strong>and<strong> Option C. Hyperflexion injury</strong> can all cause acute anterior cord syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the clinical presentation and potential causes of anterior cord syndrome.</span></span></p>",
      "correct_choice_id": 80072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20028,
      "choices": [
        {
          "id": 80073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cauda equina syndrome </span></span></p>"
        },
        {
          "id": 80074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Conus medullaris syndrome </span></span></p>"
        },
        {
          "id": 80075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lumbar disc herniation </span></span></p>"
        },
        {
          "id": 80076,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Spinal stenosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man has progressive lower back pain radiating to both legs, difficulty initiating urination, fecal incontinence, decreased perineal sensation, and weakness in ankle muscles. MRI shows a mass lesion at L1. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9194673",
      "question_audio": null,
      "question_video": null,
      "map_id": 20001,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans. </strong><strong>B) Conus medullaris syndrome </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The combination of back pain, bowel/bladder dysfunction, saddle anesthesia, and weakness in the legs with a mass lesion at L1 strongly suggests conus medullaris syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Cauda equina syndrome:</strong> Involves radicular pain and neurological deficits in the legs but usually doesn&#39;t cause bowel/bladder dysfunction as early. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lumbar disc herniation:</strong> Typically affects one leg more than the other. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Spinal stenosis:</strong> Causes gradual pain and weakness.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the signs and symptoms of conus medullaris syndrome, a neurological emergency caused by damage to the conus medullaris.</span></span></p>",
      "correct_choice_id": 80074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20029,
      "choices": [
        {
          "id": 80077,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cauda equina syndrome </span></span></p>"
        },
        {
          "id": 80078,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Conus medullaris syndrome </span></span></p>"
        },
        {
          "id": 80079,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lumbar disc herniation </span></span></p>"
        },
        {
          "id": 80080,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Spinal stenosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presents with severe lower back pain radiating to both legs, saddle anesthesia, urinary retention, fecal incontinence, decreased saddle sensation, and weakness in the lower extremities. Straight leg raise test is positive bilaterally. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8349398",
      "question_audio": null,
      "question_video": null,
      "map_id": 20002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Cauda equina syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation with bilateral radicular pain, saddle anesthesia, bowel/bladder dysfunction, and lower extremity weakness is classic for cauda equina syndrome, a surgical emergency.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Conus medullaris syndrome</strong>: Conus medullaris syndrome has a higher sensory level and upper motor neuron signs. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Disc herniation:</strong> Usually affects one leg and doesn&#39;t cause bilateral symptoms. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Spinal stenosis</strong>: Causes gradual pain and weakness.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the red flag symptoms of cauda equina syndrome, requiring urgent surgical intervention to prevent permanent neurological damage. </span></span></p>",
      "correct_choice_id": 80077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20031,
      "choices": [
        {
          "id": 80085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Duchenne muscular dystrophy </span></span></p>"
        },
        {
          "id": 80086,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myotonic dystrophy </span></span></p>"
        },
        {
          "id": 80087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Spinal muscular atrophy (SMA) </span></span></p>"
        },
        {
          "id": 80088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Congenital myopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 6-month-old infant presents with generalized muscle weakness, particularly in the proximal muscles, reduced muscle tone, absent reflexes, and a &quot;frog-leg&quot; posture. There is no family history of neuromuscular disorders. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9130946",
      "question_audio": null,
      "question_video": null,
      "map_id": 20004,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><strong>Ans.</strong><strong> C) Spinal muscular atrophy (SMA)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The infant&#39;s presentation is characteristic of SMA, a genetic disorder causing degeneration of spinal cord motor neurons, leading to progressive muscle weakness and atrophy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Duchenne muscular dystrophy</strong>: Duchenne muscular dystrophy typically presents later in childhood with progressive weakness starting in the legs. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Myotonic dystrophy</strong>: Myotonic dystrophy is characterized by myotonia (delayed muscle relaxation) and typically has a later onset. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Congenital myopathy</strong>:&nbsp;Congenital myopathies are a diverse group of muscle disorders present at birth with varying presentations.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the early signs of SMA, a common cause of infant hypotonia and weakness.</span></span></p>",
      "correct_choice_id": 80087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20032,
      "choices": [
        {
          "id": 80089,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amyotrophic lateral sclerosis (ALS) </span></span></p>"
        },
        {
          "id": 80090,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis (MS) </span></span></p>"
        },
        {
          "id": 80091,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia gravis (MG) </span></span></p>"
        },
        {
          "id": 80092,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome (GBS)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man presents with progressive right-hand weakness, muscle cramps, twitching, difficulty swallowing, slurred speech, and emotional lability. Exam reveals intrinsic hand muscle atrophy, fasciculations, increased tone, hyperreflexia, and bulbar muscle weakness. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9444046",
      "question_audio": null,
      "question_video": null,
      "map_id": 20005,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong><strong> A) Amyotrophic lateral sclerosis (ALS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The combination of upper motor neuron (spasticity, hyperreflexia) and lower motor neuron (weakness, atrophy, fasciculations) signs, along with bulbar involvement, is highly suggestive of ALS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Multiple sclerosis (MS):</strong>&nbsp;MS typically has a relapsing-remitting course with multifocal neurological deficits. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Myasthenia gravis (MG):</strong>&nbsp;MG causes fluctuating weakness that worsens with use and improves with rest. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Guillain-Barr&eacute; syndrome (GBS):</strong> GBS is an acute inflammatory demyelinating polyneuropathy with ascending weakness.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the classic presentation of ALS, a neurodegenerative disease affecting both upper and lower motor neurons.</span></span></p>",
      "correct_choice_id": 80089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20036,
      "choices": [
        {
          "id": 80105,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Riluzole </span></span></p>"
        },
        {
          "id": 80106,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pyridostigmine </span></span></p>"
        },
        {
          "id": 80107,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Prednisone </span></span></p>"
        },
        {
          "id": 80108,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous immunoglobulin (IVIG)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a 1-year history of progressive weakness in the left hand and arm, difficulty with speech and swallowing, muscle atrophy and fasciculations in the left arm, spasticity in the legs, hyperreflexia, slurred speech, and tongue weakness has a mild restrictive pattern on pulmonary function tests. Which medication can slow the progression of this disease?</span></span></p>",
      "unique_key": "Q9446041",
      "question_audio": null,
      "question_video": null,
      "map_id": 20007,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) Riluzole</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Riluzole is the only medication proven to modestly prolong survival in patients with ALS, the most likely diagnosis based on the clinical presentation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Pyridostigmine</strong>:<strong>&nbsp;</strong>Pyridostigmine is used for myasthenia gravis. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Prednisone</strong>:&nbsp;Prednisone is a corticosteroid used for inflammatory conditions.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Intravenous immunoglobulin (IVIG)</strong>: IVIG is used for immune-mediated conditions like Guillain-Barr&eacute; syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that riluzole is the only medication shown to have a modest effect on slowing the progression of ALS.</span></span></p>",
      "correct_choice_id": 80105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20038,
      "choices": [
        {
          "id": 80113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome (GBS) </span></span></p>"
        },
        {
          "id": 80114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis (MS) </span></span></p>"
        },
        {
          "id": 80115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stroke </span></span></p>"
        },
        {
          "id": 80116,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vitamin B12 deficiency</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman presents with a 1-month history of intermittent numbness and tingling in her right arm and leg, blurred vision in her left eye that resolved spontaneously, fatigue, and difficulty with balance. Exam reveals decreased sensation in the right arm and leg, intention tremor, and a positive Romberg sign. MRI shows multiple demyelinating lesions in the brain and spinal cord, some enhancing with gadolinium. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8276593",
      "question_audio": null,
      "question_video": null,
      "map_id": 20008,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Multiple sclerosis (MS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The intermittent neurological symptoms, multifocal involvement (sensory changes, optic neuritis, balance problems), and MRI findings of multiple demyelinating lesions with enhancement are highly suggestive of MS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Guillain-Barr&eacute; syndrome (GBS):</strong>&nbsp;GBS typically presents with ascending weakness and areflexia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Stroke:</strong>&nbsp;Stroke typically causes sudden onset of focal deficits. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Vitamin B12 deficiency:</strong>&nbsp;Vitamin B12 deficiency can cause neurological symptoms but not the typical MRI findings of MS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the typical presentation and MRI findings of multiple sclerosis, a chronic inflammatory demyelinating disease of the CNS.</span></span></p>",
      "correct_choice_id": 80114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20041,
      "choices": [
        {
          "id": 80125,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose intravenous corticosteroids </span></span></p>"
        },
        {
          "id": 80126,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plasmapheresis </span></span></p>"
        },
        {
          "id": 80127,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Interferon beta-1a </span></span></p>"
        },
        {
          "id": 80128,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral corticosteroids</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman with a history of two previous MS relapses presents with sudden severe left leg weakness and numbness. Exam reveals marked weakness and decreased sensation in the left leg. What is the most appropriate initial treatment?</span></span></p>",
      "unique_key": "Q8511586",
      "question_audio": null,
      "question_video": null,
      "map_id": 20010,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong> <strong>A) High-dose intravenous corticosteroids</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose intravenous corticosteroids are the first-line treatment for acute relapses in multiple sclerosis. They aim to reduce inflammation and shorten the duration of the relapse.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Plasmapheresis:</strong> &nbsp;Plasmapheresis is considered for severe relapses not responding to corticosteroids. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Interferon beta-1a:</strong> Interferon beta-1a is a disease-modifying therapy for long-term management, not acute relapses. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Oral corticosteroids:</strong> Oral corticosteroids may be used for less severe relapses or as a taper after IV steroids.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the use of high-dose intravenous corticosteroids as the initial treatment for acute relapses in multiple sclerosis. </span></span></p>",
      "correct_choice_id": 80125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54223,
      "choices": [
        {
          "id": 216361,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose intravenous corticosteroids as maintenance therapy </span></span></p>"
        },
        {
          "id": 216362,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Interferon beta-1a </span></span></p>"
        },
        {
          "id": 216363,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plasmapheresis </span></span></p>"
        },
        {
          "id": 216364,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Natalizumab</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 35-year-old man is diagnosed with relapsing-remitting multiple sclerosis (RRMS) after an episode of optic neuritis and MRI findings of demyelinating lesions. He&#39;s had two relapses requiring corticosteroids. He now has mild left-sided weakness and decreased sensation in his right leg. What is the most appropriate first-line treatment for his MS?</span></span></p>",
      "unique_key": "Q9902853",
      "question_audio": null,
      "question_video": null,
      "map_id": 25717,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong> <strong>B) Interferon beta-1a</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Interferon beta-1a is a first-line disease-modifying therapy for RRMS, shown to reduce relapse frequency and severity, and delay disability progression.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. High-dose intravenous corticosteroids as maintenance therapy:&nbsp;</strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose IV corticosteroids are for acute relapses, not maintenance. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasmapheresis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmapheresis is for severe, refractory relapses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Natalizumab: </strong>Natalizumab is a second-line option due to the risk of progressive multifocal leukoencephalopathy (PML).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the role of interferon beta-1a as a first-line disease-modifying therapy for RRMS.</span></span></p>",
      "correct_choice_id": 216362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54224,
      "choices": [
        {
          "id": 216365,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Presence of both brain and spinal cord lesions on MRI </span></span></p>"
        },
        {
          "id": 216366,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Demonstration of dissemination in space (DIS) and time (DIT) on MRI </span></span></p>"
        },
        {
          "id": 216367,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Detection of oligoclonal bands in cerebrospinal fluid </span></span></p>"
        },
        {
          "id": 216368,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">History of multiple neurological symptoms</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents with sudden right-sided weakness and difficulty with coordination, as well as a prior episode of transient left-sided facial numbness. Which finding best supports a diagnosis of MS according to the McDonald criteria?</span></span></p>",
      "unique_key": "Q6017696",
      "question_audio": null,
      "question_video": null,
      "map_id": 25718,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Demonstration of dissemination in space (DIS) and time (DIT) on MRI</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The McDonald criteria for MS diagnosis require evidence of DIS (lesions in different CNS areas) and DIT (lesions of different ages). This patient&#39;s MRI demonstrates both, with lesions in the brain and spinal cord (DIS), and both enhancing (new) and non-enhancing (old) lesions (DIT).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Presence of both brain and spinal cord lesions on MRI:</strong>&nbsp;While this shows DIS, it doesn&#39;t confirm DIT.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Detection of oligoclonal bands in cerebrospinal fluid:</strong>&nbsp;Oligoclonal bands are supportive, but not the primary criterion. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. History of multiple neurological symptoms:</strong>&nbsp;Multiple episodes are suggestive, but MRI findings are more definitive.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the importance of demonstrating dissemination in space and time on MRI for diagnosing MS according to the McDonald criteria.</span></span></p>",
      "correct_choice_id": 216366,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54225,
      "choices": [
        {
          "id": 216369,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Progressive multifocal leukoencephalopathy (PML) </span></span></p>"
        },
        {
          "id": 216370,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute disseminated encephalomyelitis (ADEM) </span></span></p>"
        },
        {
          "id": 216371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Central pontine myelinolysis (CPM) </span></span></p>"
        },
        {
          "id": 216372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">MS rebound syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old woman with RRMS on natalizumab for 2 years presents with progressive weakness, confusion, personality changes, and new non-enhancing white matter lesions on MRI. Which serious side effect of natalizumab is suggested?</span></span></p>",
      "unique_key": "Q3323693",
      "question_audio": null,
      "question_video": null,
      "map_id": 25719,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Progressive multifocal leukoencephalopathy (PML)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PML is a rare but serious complication of natalizumab, presenting with progressive neurological decline and non-enhancing white matter lesions on MRI.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Acute disseminated encephalomyelitis (ADEM):</strong>&nbsp;ADEM is an acute inflammatory demyelinating disorder not specifically linked to natalizumab. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Central pontine myelinolysis (CPM):</strong>&nbsp;CPM is associated with rapid correction of hyponatremia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. MS rebound syndrome:</strong>&nbsp;MS rebound is a potential risk after stopping natalizumab, not while on it.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Be aware of the risk of PML with natalizumab and its presentation.</span></span></p>",
      "correct_choice_id": 216369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54226,
      "choices": [
        {
          "id": 216373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis (MS) </span></span></p>"
        },
        {
          "id": 216374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Neuromyelitis optica spectrum disorder (NMOSD) </span></span></p>"
        },
        {
          "id": 216375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute disseminated encephalomyelitis (ADEM) </span></span></p>"
        },
        {
          "id": 216376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Optic neuritis of unknown etiology</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old woman presents with worsening vision in her right eye, eye pain with movement, recent severe back pain, and leg weakness/numbness. Exam reveals vision loss in the right eye with RAPD and longitudinally extensive transverse myelitis (LETM) on spinal MRI. Serum AQP4 antibodies are positive. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q3512874",
      "question_audio": null,
      "question_video": null,
      "map_id": 25720,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Neuromyelitis optica spectrum disorder (NMOSD)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The combination of optic neuritis, LETM on MRI, and positive AQP4 antibodies is highly specific for NMOSD.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Explanation:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Multiple sclerosis (MS):</strong>&nbsp;MS can have similar symptoms, but the LETM and AQP4 antibodies are more characteristic of NMOSD. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Acute disseminated encephalomyelitis (ADEM):</strong>&nbsp;ADEM is an acute demyelinating disorder, not usually associated with AQP4 antibodies. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Optic neuritis of unknown etiology:</strong>&nbsp;Isolated optic neuritis is less likely given the spinal cord involvement and positive AQP4 antibodies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the distinct clinical and laboratory features of NMOSD, differentiating it from MS.</span></span></p>",
      "correct_choice_id": 216374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54227,
      "choices": [
        {
          "id": 216377,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Positive aquaporin-4 antibody (AQP4-IgG) serostatus </span></span></p>"
        },
        {
          "id": 216378,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An episode of optic neuritis, myelitis, or area postrema syndrome </span></span></p>"
        },
        {
          "id": 216379,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Presence of oligoclonal bands in CSF </span></span></p>"
        },
        {
          "id": 216380,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">At least one core clinical characteristic in the absence of AQP4-IgG</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT part of the 2015 International Consensus Diagnostic Criteria for NMOSD?</span></span></p>",
      "unique_key": "Q8564670",
      "question_audio": null,
      "question_video": null,
      "map_id": 25721,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Presence of oligoclonal bands in CSF</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oligoclonal bands are more commonly seen in MS and are not a diagnostic criterion for NMOSD.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Positive aquaporin-4 antibody (AQP4-IgG) serostatus, Option B. An episode of optic neuritis, myelitis, or area postrema syndrome </strong>and<strong> Option D. At least one core clinical characteristic in the absence of AQP4-IgG</strong> are all part of the diagnostic criteria for NMOSD.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the specific diagnostic criteria for NMOSD, including the importance of AQP4 antibodies and core clinical characteristics.</span></span></p>",
      "correct_choice_id": 216379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54228,
      "choices": [
        {
          "id": 216381,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis (MS) </span></span></p>"
        },
        {
          "id": 216382,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute disseminated encephalomyelitis (ADEM) </span></span></p>"
        },
        {
          "id": 216383,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bacterial meningitis </span></span></p>"
        },
        {
          "id": 216384,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cerebral abscess</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy presents with sudden-onset fever, headache, confusion, hyperreflexia, and bilateral Babinski signs following a recent upper respiratory tract infection. MRI shows multiple, bilateral, asymmetric lesions involving both white and gray matter with no enhancement after contrast administration. Lumbar puncture reveals mild lymphocytic pleocytosis with normal glucose and elevated protein levels. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q5214803",
      "question_audio": null,
      "question_video": null,
      "map_id": 25722,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Acute disseminated encephalomyelitis (ADEM)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation (fever, headache, confusion, hyperreflexia, Babinski signs) following a recent infection, along with MRI findings of multiple asymmetric white and gray matter lesions without enhancement, and CSF showing mild lymphocytic pleocytosis and elevated protein, are highly characteristic of ADEM.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Multiple sclerosis (MS):</strong> MS typically has a relapsing-remitting course and more discrete lesions on MRI. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Bacterial meningitis:</strong> Bacterial meningitis usually presents with higher fever, nuchal rigidity, and CSF findings of elevated neutrophils and low glucose. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Cerebral abscesses:</strong> Cerebral abscesses typically cause focal neurological deficits and appear as ring-enhancing lesions on MRI.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the clinical and imaging features of ADEM, an acute inflammatory demyelinating disorder often following infection or vaccination.</span></span></p>",
      "correct_choice_id": 216382,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54229,
      "choices": [
        {
          "id": 216385,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Autoimmune diseases </span></span></p>"
        },
        {
          "id": 216386,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Compression or trauma </span></span></p>"
        },
        {
          "id": 216387,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic disorders </span></span></p>"
        },
        {
          "id": 216388,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Infectious diseases</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common cause of mononeuropathy?</span></span></p>",
      "unique_key": "Q1678674",
      "question_audio": null,
      "question_video": null,
      "map_id": 25723,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B) Compression or trauma</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mononeuropathy, the damage or disease of a single nerve, is most often caused by local factors like compression or trauma. Common examples include carpal tunnel syndrome and peroneal neuropathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Autoimmune diseases:</strong> Autoimmune diseases more commonly cause multiple nerve involvement (polyneuropathy). </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Metabolic disorders:</strong> Metabolic disorders (e.g., diabetes) can cause neuropathy, but it&#39;s usually a polyneuropathy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Infectious diseases:</strong> Infectious diseases can cause neuropathy, but it&#39;s less common than compression/trauma as a cause of mononeuropathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that the most common cause of mononeuropathy is compression or trauma.</span></span></p>",
      "correct_choice_id": 216386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54235,
      "choices": [
        {
          "id": 216409,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">SSRIs </span></span></p>"
        },
        {
          "id": 216410,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">TCAs </span></span></p>"
        },
        {
          "id": 216411,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">SNRIs </span></span></p>"
        },
        {
          "id": 216412,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Calcium channel blockers (gabapentinoids)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 45-year-old woman with chronic lower back pain and burning/electric shock-like pain radiating down her left leg has sensory loss in the L5 dermatome. She is cautious about using NSAIDs due to peptic ulcer disease. Which is NOT a first-line treatment for her pain?</span></span></p>",
      "unique_key": "Q8984311",
      "question_audio": null,
      "question_video": null,
      "map_id": 25729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) SSRIs</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">While TCAs, SNRIs, and gabapentinoids are first-line for neuropathic pain, SSRIs are not typically used as first-line due to lower efficacy in this type of pain.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. TCAs, Option C. SNRIs </strong>and<strong> Option D. Calcium channel blockers (gabapentinoids)</strong> are all considered first-line treatments for neuropathic pain.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize that SSRIs are not typically first-line for neuropathic pain, while TCAs, SNRIs, and gabapentinoids are.</span></span></p>",
      "correct_choice_id": 216409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54236,
      "choices": [
        {
          "id": 216413,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome (GBS) </span></span></p>"
        },
        {
          "id": 216414,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis (MS) </span></span></p>"
        },
        {
          "id": 216415,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amyotrophic lateral sclerosis (ALS) </span></span></p>"
        },
        {
          "id": 216416,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia gravis (MG)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old man has progressive ascending weakness in both legs and arms over 2 days, preceded by a diarrheal illness 10 days prior. Exam reveals symmetrical weakness, areflexia, and mild sensory loss. CSF shows elevated protein with normal white cell count. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q5750537",
      "question_audio": null,
      "question_video": null,
      "map_id": 25730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans.</strong> <strong>A) Guillain-Barr&eacute; syndrome (GBS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ascending weakness, areflexia, and albuminocytologic dissociation (elevated CSF protein with normal cell count) following a recent infection are classic for GBS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Multiple sclerosis (MS):&nbsp;</strong>MS usually has a relapsing-remitting course and different MRI findings.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Amyotrophic lateral sclerosis (ALS): </strong>ALS is a progressive neurodegenerative disease with upper and lower motor neuron signs. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Myasthenia gravis (MG):</strong>&nbsp;MG causes fluctuating weakness that worsens with use.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the typical presentation and CSF findings of Guillain-Barr&eacute; syndrome. </span></span></p>",
      "correct_choice_id": 216413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54237,
      "choices": [
        {
          "id": 216417,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome (GBS) </span></span></p>"
        },
        {
          "id": 216418,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Miller Fisher syndrome (MFS) </span></span></p>"
        },
        {
          "id": 216419,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia gravis (MG) </span></span></p>"
        },
        {
          "id": 216420,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Brainstem stroke</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old man has progressive difficulty walking, double vision, and incomplete eyelid closure over the past week, preceded by an upper respiratory tract infection 3 weeks prior. He has bilateral limb weakness, areflexia, and normal sensation. Lumbar puncture shows elevated protein with normal white cell count. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q4280720",
      "question_audio": null,
      "question_video": null,
      "map_id": 25731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Miller Fisher syndrome (MFS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B</strong>: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The triad of ophthalmoplegia (double vision, incomplete eyelid closure), ataxia (difficulty walking), and areflexia, along with a recent respiratory infection and albuminocytologic dissociation in CSF, are classic for MFS, a variant of GBS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Guillain-Barr&eacute; syndrome (GBS):</strong>&nbsp;GBS can have similar features but usually lacks the prominent ophthalmoplegia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Myasthenia gravis (MG):</strong>&nbsp;MG typically presents with fluctuating weakness and fatigability, not ataxia or areflexia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Brainstem stroke:</strong> Brainstem stroke would likely have other focal neurological deficits and abnormal imaging.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the characteristic triad of MFS and its association with recent infection.</span></span></p>",
      "correct_choice_id": 216418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54238,
      "choices": [
        {
          "id": 216421,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous immunoglobulin (IVIG) </span></span></p>"
        },
        {
          "id": 216422,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral corticosteroids </span></span></p>"
        },
        {
          "id": 216423,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plasmapheresis </span></span></p>"
        },
        {
          "id": 216424,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intubation and mechanical ventilation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with GBS is admitted to the ICU due to rapidly progressive weakness and respiratory distress. Which of the following is the MOST appropriate initial management?</span></span></p>",
      "unique_key": "Q8053612",
      "question_audio": null,
      "question_video": null,
      "map_id": 25732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans. </strong><strong>D) Intubation and mechanical ventilation</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a patient with GBS presenting with respiratory distress and rapidly progressive weakness, the immediate priority is to secure the airway and ensure adequate ventilation. This is because respiratory failure is a life-threatening complication of GBS. Therefore, intubation and mechanical ventilation are the most appropriate initial management steps.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Intravenous immunoglobulin (IVIG) </strong>and<strong> Option C. Plasmapheresis:</strong> While IVIG and plasmapheresis are effective treatments for GBS, they are immunomodulatory therapies that take time to work. They are not the immediate priority in a patient with respiratory distress.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Oral corticosteroids:</strong> Corticosteroids are not beneficial in GBS and may even worsen the outcome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize that the immediate priority in managing a patient with GBS and respiratory distress is to secure the airway and initiate mechanical ventilation before considering immunomodulatory therapies.</span></span></p>",
      "correct_choice_id": 216424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54239,
      "choices": [
        {
          "id": 216425,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Significantly elevated WBCs with lymphocytic predominance </span></span></p>"
        },
        {
          "id": 216426,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Albumino-cytological dissociation </span></span></p>"
        },
        {
          "id": 216427,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Decreased glucose </span></span></p>"
        },
        {
          "id": 216428,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oligoclonal bands</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with rapidly ascending muscle weakness, areflexia, and mild sensory loss following gastroenteritis has a lumbar puncture. What CSF finding is most indicative of their condition?</span></span></p>",
      "unique_key": "Q8234078",
      "question_audio": null,
      "question_video": null,
      "map_id": 25733,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Albumino-cytological dissociation</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation is consistent with Guillain-Barr&eacute; syndrome (GBS). The most characteristic CSF finding in GBS is albuminocytological dissociation (elevated protein with normal WBC count).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Significantly elevated WBCs with lymphocytic predominance:</strong> Elevated WBCs suggest infection, not GBS. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Decreased glucose:</strong> Decreased glucose suggests bacterial/fungal infection. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Oligoclonal bands:</strong> Oligoclonal bands are associated with multiple sclerosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize albuminocytologic dissociation as a key CSF finding in Guillain-Barr&eacute; syndrome.</span></span></p>",
      "correct_choice_id": 216426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54240,
      "choices": [
        {
          "id": 216429,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose oral corticosteroids </span></span></p>"
        },
        {
          "id": 216430,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous immunoglobulin (IVIG) therapy </span></span></p>"
        },
        {
          "id": 216431,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plasmapheresis (plasma exchange) </span></span></p>"
        },
        {
          "id": 216432,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Broad-spectrum antibiotics</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman with rapidly progressing ascending weakness and tingling is diagnosed with Guillain-Barr&eacute; syndrome (GBS). What is the most appropriate initial treatment?</span></span></p>",
      "unique_key": "Q8472278",
      "question_audio": null,
      "question_video": null,
      "map_id": 25734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Intravenous immunoglobulin (IVIG) therapy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IVIG and plasmapheresis are the most effective initial treatments for GBS. IVIG is often preferred due to its ease of administration and fewer potential complications.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. High-dose oral corticosteroids</strong>: Corticosteroids are not beneficial in GBS. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Plasmapheresis</strong>: Plasmapheresis is an alternative to IVIG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Broad-spectrum antibiotics</strong>: Antibiotics are not indicated for GBS, which is immune-mediated.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that IVIG and plasmapheresis are the first-line treatments for GBS.</span></span></p>",
      "correct_choice_id": 216430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54241,
      "choices": [
        {
          "id": 216433,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome </span></span></p>"
        },
        {
          "id": 216434,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sclerosis </span></span></p>"
        },
        {
          "id": 216435,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia gravis </span></span></p>"
        },
        {
          "id": 216436,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lambert-Eaton myasthenic syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman presents with fluctuating muscle weakness worsening in the evening, difficulty keeping her eyelids open, double vision, and difficulty chewing. Symptoms improve with rest. Exam shows bilateral ptosis and diplopia on sustained upward gaze. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2608939",
      "question_audio": null,
      "question_video": null,
      "map_id": 25735,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Myasthenia gravis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fluctuating weakness, especially in the ocular and bulbar muscles, that worsens with activity and improves with rest is classic for myasthenia gravis (MG).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Guillain-Barr&eacute; syndrome (GBS)</strong>: GBS is an acute ascending paralysis. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Multiple sclerosis (MS)</strong>:&nbsp;MS is a chronic demyelinating disease with diverse symptoms. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Lambert-Eaton myasthenic syndrome (LEMS)</strong>:<strong> </strong>LEMS is similar to MG but improves with repetitive exercise.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the characteristic features of myasthenia gravis, including fluctuating weakness, ocular symptoms, and fatigability.</span></span></p>",
      "correct_choice_id": 216435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54242,
      "choices": [
        {
          "id": 216437,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia gravis (MG)</span></span></p>"
        },
        {
          "id": 216438,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain-Barr&eacute; syndrome (GBS)</span></span></p>"
        },
        {
          "id": 216439,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lambert-Eaton myasthenic syndrome (LEMS) </span></span></p>"
        },
        {
          "id": 216440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polymyositis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man with a smoking history has progressive proximal muscle weakness, dry mouth, erectile dysfunction, and a cough. The weakness improves with continued use. Exam shows proximal muscle weakness, diminished reflexes at rest with incremental response upon repetitive stimulation. A chest CT reveals a lung mass. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7144541",
      "question_audio": null,
      "question_video": null,
      "map_id": 25736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Lambert-Eaton myasthenic syndrome (LEMS)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The proximal muscle weakness that improves with use, autonomic dysfunction (dry mouth, erectile dysfunction), lung mass, and incremental reflex response are characteristic of LEMS, a paraneoplastic syndrome often associated with small cell lung cancer.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Myasthenia gravis (MG)</strong>: MG worsens with use, not improves. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Guillain-Barr&eacute; syndrome (GBS)</strong>: GBS is acute and ascending. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Polymyositis</strong>: Polymyositis does not improve with use or have autonomic symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the characteristic features of LEMS, a paraneoplastic syndrome often associated with small cell lung cancer. </span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 216439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54243,
      "choices": [
        {
          "id": 216441,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">High-dose corticosteroids </span></span></p>"
        },
        {
          "id": 216442,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pyridostigmine therapy </span></span></p>"
        },
        {
          "id": 216443,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immediate thymectomy </span></span></p>"
        },
        {
          "id": 216444,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous immunoglobulin (IVIG) therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman presents with complaints of double vision and drooping eyelids, especially at the end of the day or after prolonged reading. She also reports difficulty swallowing and arm weakness after repetitive tasks. Her symptoms improve after resting. On examination, she has bilateral ptosis and diplopia with sustained upward gaze. Acetylcholine receptor antibodies are positive. What is the most appropriate initial treatment for this patient?</span></span></p>",
      "unique_key": "Q6907173",
      "question_audio": null,
      "question_video": null,
      "map_id": 25737,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans. </strong><strong>B) Pyridostigmine therapy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The patient&#39;s presentation and positive acetylcholine receptor antibodies are consistent with myasthenia gravis (MG). Pyridostigmine, an acetylcholinesterase inhibitor, is the first-line treatment for MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. High-dose corticosteroids</strong>: Corticosteroids are used for severe or refractory MG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Immediate thymectomy</strong>: Thymectomy may be considered later for certain patients with MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Intravenous immunoglobulin (IVIG) therapy</strong>: IVIG is reserved for acute exacerbations or refractory MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the presentation of myasthenia gravis and the role of pyridostigmine as the initial treatment.</span></span></p>",
      "correct_choice_id": 216442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54244,
      "choices": [
        {
          "id": 216445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increase the dose of pyridostigmine. </span></span></p>"
        },
        {
          "id": 216446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate corticosteroids and consider adding rituximab. </span></span></p>"
        },
        {
          "id": 216447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Schedule immediate thymectomy. </span></span></p>"
        },
        {
          "id": 216448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Prescribe cholinesterase inhibitors as the sole treatment.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 41-year-old woman presents with muscle weakness in her neck and bulbar muscles, difficulty holding her head upright, and problems with speech and swallowing. She also reports double vision. Symptoms have worsened over 6 months. Acetylcholine receptor antibodies are negative, but muscle-specific kinase (MuSK) antibodies are positive. Pyridostigmine provides minimal improvement. What is the most appropriate next step in management?</span></span></p>",
      "unique_key": "Q4868812",
      "question_audio": null,
      "question_video": null,
      "map_id": 25738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Initiate corticosteroids and consider adding rituximab.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This patient has MuSK antibody-positive MG, a subtype that often responds poorly to pyridostigmine. Corticosteroids are the first-line immunosuppressive therapy, and rituximab can be added for refractory cases.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Increase the dose of pyridostigmine</strong>: Increasing pyridostigmine is unlikely to be effective. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Schedule immediate thymectomy</strong>: Thymectomy is less beneficial in MuSK MG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Prescribe cholinesterase inhibitors as the sole treatment</strong>:<strong> </strong>Cholinesterase inhibitors alone are insufficient for MuSK MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the management of MuSK antibody-positive MG, which often requires immunosuppressive therapy.</span></span></p>",
      "correct_choice_id": 216446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54245,
      "choices": [
        {
          "id": 216449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients over 60 with mild symptoms </span></span></p>"
        },
        {
          "id": 216450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients with purely ocular symptoms </span></span></p>"
        },
        {
          "id": 216451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients with thymoma, regardless of symptom severity </span></span></p>"
        },
        {
          "id": 216452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients in medication-induced remission</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with myasthenia gravis, thymectomy is most commonly indicated in which scenario?</span></span></p>",
      "unique_key": "Q8027463",
      "question_audio": null,
      "question_video": null,
      "map_id": 25739,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> C) Patients with thymoma, regardless of symptom severity</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thymectomy is indicated in all patients with MG who have a thymoma (a tumor of the thymus gland), regardless of their MG symptom severity, due to the potential for the tumor to worsen or cause a relapse of MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Patients over 60 with mild symptoms</strong>: Thymectomy is generally not recommended in older patients with mild MG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Patients with purely ocular symptoms</strong>:<strong> </strong>Thymectomy is considered less often in ocular MG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Patients in medication-induced remission</strong>: Medication-induced remission does not negate the need for thymectomy if a thymoma is present.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the importance of thymectomy in MG patients with thymoma.</span></span></p>",
      "correct_choice_id": 216451,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54246,
      "choices": [
        {
          "id": 216453,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Spinal Muscular Atrophy (SMA) </span></span></p>"
        },
        {
          "id": 216454,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Duchenne Muscular Dystrophy (DMD) </span></span></p>"
        },
        {
          "id": 216455,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Becker Muscular Dystrophy (BMD) </span></span></p>"
        },
        {
          "id": 216456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Charcot-Marie-Tooth Disease (CMT)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old boy presents with difficulty running, frequent falls, Gowers&#39; sign, and calf pseudohypertrophy. He was late to start walking and has always been clumsy. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7504786",
      "question_audio": null,
      "question_video": null,
      "map_id": 25740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Duchenne Muscular Dystrophy (DMD)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The classic presentation of a young boy with proximal muscle weakness, Gowers&#39; sign, calf pseudohypertrophy, and delayed motor milestones strongly suggests Duchenne muscular dystrophy (DMD).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Spinal Muscular Atrophy (SMA)</strong>: SMA presents with progressive weakness and atrophy, but typically not with Gowers&#39; sign or pseudohypertrophy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Becker Muscular Dystrophy (BMD)</strong>: BMD is a milder form of muscular dystrophy with a later onset.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Charcot-Marie-Tooth Disease (CMT)</strong>: CMT primarily affects the peripheral nerves, leading to distal weakness and sensory loss.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the clinical features of DMD, a severe X-linked recessive muscular dystrophy.</span></span></p>",
      "correct_choice_id": 216454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54247,
      "choices": [
        {
          "id": 216457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Incremental response </span></span></p>"
        },
        {
          "id": 216458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Decremental response at low-frequency stimulation </span></span></p>"
        },
        {
          "id": 216459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Normal response to both low and high-frequency stimulation </span></span></p>"
        },
        {
          "id": 216460,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Prolonged direct muscle stimulation response</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following repetitive nerve stimulation (RNS) findings is most commonly associated with myasthenia gravis?</span></span></p>",
      "unique_key": "Q8143544",
      "question_audio": null,
      "question_video": null,
      "map_id": 25741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Decremental response at low-frequency stimulation</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong> <strong>B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In MG, there&#39;s a decrease in the amplitude of compound muscle action potentials (CMAPs) with repetitive nerve stimulation at low frequencies due to impaired neuromuscular transmission.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Incremental response</strong>: Incremental response is seen in Lambert-Eaton myasthenic syndrome. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Normal response to both low and high-frequency stimulation</strong>: A normal response would not be expected in MG. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Prolonged direct muscle stimulation response</strong>: Prolonged direct muscle stimulation response is not characteristic of MG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the diagnostic utility of repetitive nerve stimulation in MG, specifically the decremental response at low frequencies.</span></span></p>",
      "correct_choice_id": 216458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54248,
      "choices": [
        {
          "id": 216461,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Duchenne Muscular Dystrophy (DMD) </span></span></p>"
        },
        {
          "id": 216462,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Becker Muscular Dystrophy (BMD) </span></span></p>"
        },
        {
          "id": 216463,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myotonic Dystrophy </span></span></p>"
        },
        {
          "id": 216464,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Limb-Girdle Muscular Dystrophy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy presents with difficulty running, frequent falls, and using Gowers&#39; sign to stand up. He has calf muscle hypertrophy and elevated serum creatine kinase (CK) levels. What is the diagnosis?</span></span></p>",
      "unique_key": "Q8975770",
      "question_audio": null,
      "question_video": null,
      "map_id": 25742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> B) Becker Muscular Dystrophy (BMD)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The later onset of weakness, difficulty running/climbing, calf hypertrophy, and elevated CK point to BMD, a milder form of muscular dystrophy compared to DMD, which presents earlier with more rapid progression.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Duchenne Muscular Dystrophy (DMD)</strong>: DMD presents earlier in childhood (3-5 years) with more rapid progression. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Myotonic Dystrophy</strong>:<strong> </strong>Myotonic dystrophy is associated with myotonia, facial weakness, and multisystem involvement. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Limb-Girdle Muscular Dystrophy</strong>: Limb-Girdle MD affects shoulders and hips, not calves.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Differentiate Becker MD from Duchenne MD based on age of onset and clinical presentation.</span></span></p>",
      "correct_choice_id": 216462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54249,
      "choices": [
        {
          "id": 216465,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polymyositis </span></span></p>"
        },
        {
          "id": 216466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia Gravis </span></span></p>"
        },
        {
          "id": 216467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myotonic Dystrophy </span></span></p>"
        },
        {
          "id": 216468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple Sclerosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents with difficulty releasing his grip (myotonia), muscle stiffness, facial weakness, temporalis and masseter muscle atrophy, cataracts, daytime sleepiness, and constipation. EMG shows myotonic discharges. What is the diagnosis?</span></span></p>",
      "unique_key": "Q8461227",
      "question_audio": null,
      "question_video": null,
      "map_id": 25743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Myotonic Dystrophy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The combination of myotonia, muscle weakness, facial weakness, systemic symptoms (cataracts, sleepiness, constipation), and myotonic discharges on EMG is characteristic of myotonic dystrophy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Polymyositis</strong>: Polymyositis is an inflammatory myopathy with proximal muscle weakness and elevated muscle enzymes. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Myasthenia gravis</strong>: Myasthenia gravis presents with fluctuating weakness, often with ocular involvement.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Multiple sclerosis</strong>: Multiple sclerosis is a demyelinating disease with a wide range of symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the multisystemic manifestations of myotonic dystrophy.</span></span></p>",
      "correct_choice_id": 216467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54250,
      "choices": [
        {
          "id": 216469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Facioscapulohumeral Muscular Dystrophy (FSHD) </span></span></p>"
        },
        {
          "id": 216470,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Emery-Dreifuss Muscular Dystrophy (EDMD) </span></span></p>"
        },
        {
          "id": 216471,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Becker Muscular Dystrophy (BMD) </span></span></p>"
        },
        {
          "id": 216472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Duchenne Muscular Dystrophy (DMD)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy presents with muscle weakness, elbow contractures, weak upper arm and calf muscles, mild scoliosis, and ECG conduction abnormalities:</span></span></p>",
      "unique_key": "Q5660774",
      "question_audio": null,
      "question_video": null,
      "map_id": 25744,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Ans. </strong><strong>B) Emery-Dreifuss Muscular Dystrophy (EDMD)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Early contractures, weakness in specific muscle groups (upper arms and calves), and cardiac conduction abnormalities are classic for EDMD.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Facioscapulohumeral Muscular Dystrophy (FSHD)</strong>:<strong>&nbsp;</strong>FSHD typically affects facial, shoulder, and upper arm muscles without early contractures or significant cardiac involvement. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Becker Muscular Dystrophy (BMD)</strong>:&nbsp;BMD presents with later onset and predominantly affects proximal muscles. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Duchenne Muscular Dystrophy (DMD)</strong>:&nbsp;DMD has an earlier onset and more severe progression.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the early contractures and cardiac involvement as key features of Emery-Dreifuss Muscular Dystrophy.</span></span></p>",
      "correct_choice_id": 216470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54251,
      "choices": [
        {
          "id": 216473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diabetes mellitus </span></span></p>"
        },
        {
          "id": 216474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Alcohol </span></span></p>"
        },
        {
          "id": 216475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Chemotherapy </span></span></p>"
        },
        {
          "id": 216476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amyloidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54-year-old woman has progressive numbness, tingling, and burning pain in her hands and feet, worse at night. Examination shows loss of pinprick and temperature sensation in a stocking-glove distribution. Nerve conduction studies are normal, but a skin biopsy shows reduced intraepidermal nerve fiber density. What is least likely?</span></span></p>",
      "unique_key": "Q5089324",
      "question_audio": null,
      "question_video": null,
      "map_id": 25745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> D) Amyloidosis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation and skin biopsy findings are consistent with small fiber neuropathy. Diabetes, alcohol, and chemotherapy are common causes of small fiber neuropathy. Amyloidosis typically affects both small and large fibers, causing abnormalities in nerve conduction studies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Diabetes mellitus</strong>: Diabetes is a common cause of small fiber neuropathy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Alcohol</strong>: Alcohol is a common cause of small fiber neuropathy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Chemotherapy</strong>: Chemotherapy can cause small fiber neuropathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize small fiber neuropathy as a distinct entity and be aware of its common causes.</span></span></p>",
      "correct_choice_id": 216476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54252,
      "choices": [
        {
          "id": 216477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ulnar nerve </span></span></p>"
        },
        {
          "id": 216478,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Radial nerve </span></span></p>"
        },
        {
          "id": 216479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Median nerve </span></span></p>"
        },
        {
          "id": 216480,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Musculocutaneous nerve</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female complains of numbness and tingling in her thumb, index finger, and middle finger. Symptoms are worse at night and improve with shaking her hand. Which nerve is most likely affected?</span></span></p>",
      "unique_key": "Q1732165",
      "question_audio": null,
      "question_video": null,
      "map_id": 25746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>C) Median nerve</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The symptoms described are classic for carpal tunnel syndrome, a condition where the median nerve is compressed as it passes through the carpal tunnel at the wrist. This nerve innervates the thumb, index, middle finger, and the radial half of the ring finger. The numbness and tingling are often worse at night due to wrist flexion during sleep. Shaking the hand can temporarily relieve the symptoms by improving blood flow and reducing nerve compression.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Ulnar nerve</strong>: The ulnar nerve supplies the little finger and the ulnar half of the ring finger. Compression of this nerve would result in symptoms in these fingers.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Radial nerve</strong>: The radial nerve supplies the back of the hand and the thumb side of the forearm. Compression of this nerve would cause weakness and sensory loss in these areas.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Musculocutaneous nerve</strong>: The musculocutaneous nerve supplies the muscles of the front of the upper arm and the skin on the radial side of the forearm. Compression of this nerve would cause weakness in elbow flexion and sensory loss in the forearm.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the classic presentation of carpal tunnel syndrome, including the distribution of symptoms and the characteristic features of worsening at night and improvement with shaking the hand. This knowledge is essential for early diagnosis and appropriate management.</span></span></p>",
      "correct_choice_id": 216479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54254,
      "choices": [
        {
          "id": 216485,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metformin </span></span></p>"
        },
        {
          "id": 216486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Atorvastatin </span></span></p>"
        },
        {
          "id": 216487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lisinopril </span></span></p>"
        },
        {
          "id": 216488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amiodarone</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is known to cause peripheral neuropathy as a side effect?</span></span></p>",
      "unique_key": "Q3509170",
      "question_audio": null,
      "question_video": null,
      "map_id": 25748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>D) Amiodarone</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amiodarone is an antiarrhythmic medication used to treat irregular heartbeats. It is well-known to cause peripheral neuropathy, often presenting as numbness and tingling in the hands and feet. This is due to its accumulation in nerve tissue over time.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Metformin</strong>: Metformin is an oral antidiabetic medication. It is not typically associated with peripheral neuropathy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Atorvastatin</strong>: Atorvastatin is a statin medication used to lower cholesterol levels. While rare cases of muscle pain (myopathy) have been reported, peripheral neuropathy is not a common side effect. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lisinopril</strong>: Lisinopril is an ACE inhibitor used to treat high blood pressure and heart failure. It is not known to cause peripheral neuropathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Be aware that amiodarone can cause peripheral neuropathy as a side effect and monitor patients on this medication for neurological symptoms.</span></span></p>",
      "correct_choice_id": 216488,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54255,
      "choices": [
        {
          "id": 216489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Chronic inflammatory demyelinating polyneuropathy (CIDP) </span></span></p>"
        },
        {
          "id": 216490,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diabetic peripheral neuropathy </span></span></p>"
        },
        {
          "id": 216491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amyloid neuropathy </span></span></p>"
        },
        {
          "id": 216492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Paraneoplastic neuropathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male with a history of monoclonal gammopathy presents with progressive weakness and sensory loss in his legs. Nerve conduction studies reveal demyelinating neuropathy. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2787409",
      "question_audio": null,
      "question_video": null,
      "map_id": 25749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Amyloid neuropathy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Monoclonal gammopathies are strongly associated with amyloid neuropathy. The deposition of amyloid protein in peripheral nerves leads to a progressive, predominantly sensory and autonomic neuropathy, often with early involvement of small fibers. The demyelinating pattern on nerve conduction studies further supports this diagnosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Chronic inflammatory demyelinating polyneuropathy (CIDP)</strong>: While CIDP is a demyelinating neuropathy, it is not typically associated with monoclonal gammopathies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Diabetic peripheral neuropathy</strong>: Diabetic neuropathy is usually axonal, not demyelinating, and it presents with a more symmetrical, length-dependent pattern.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Paraneoplastic neuropathy</strong>: Paraneoplastic neuropathies are associated with underlying cancers and can present with various patterns, but the presence of monoclonal gammopathy points more towards amyloid neuropathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize that monoclonal gammopathy in a patient with progressive demyelinating neuropathy should raise a strong suspicion for amyloid neuropathy. Early diagnosis and treatment are essential for managing this condition. </span></span></p>",
      "correct_choice_id": 216491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}